NeuroSigma Announces FDA Clearance of its Second-Generation

LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s...

Related Keywords

United States , London , City Of , United Kingdom , China , Singapore , California , C Thomas Paschall , Colin Kealey , Los Angeles , Checkmate Capital Group , Drug Administration , King College London , Seattle Children , College London , Checkmate Capital , Neurosigma , Nc , Adhd , Neurological , Onarch Etns , Onarch 2 0 , Bioelectronics , Biotechnology , Biotech ,